title: Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis.
authors.affiliation: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Hisato
authors.initials: H
authors.lastname: Iriki
authors.affiliation: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. tanese@2001.jukuin.keio.ac.jp.
authors.forename: Keiji
authors.initials: K
authors.lastname: Tanese
authors.affiliation: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Furuichi
authors.affiliation: Department of Respiratory Medicine, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan.
authors.forename: Kei
authors.initials: K
authors.lastname: Takeshita
authors.affiliation: Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Masataka
authors.initials: M
authors.lastname: Saito
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood* / Q000188:drug therapy*; D015843:Serpins / Q000097:blood*; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000951:Antigens, Neoplasm; D015415:Biomarkers; D003879:Dermatologic Agents; D015843:Serpins; D014409:Tumor Necrosis Factor-alpha; C051072:squamous cell carcinoma-related antigen; D000069285:Infliximab; D000068879:Adalimumab